产品详情 |
Edit |   |
Product Name | Recombinant Human CCL18/PARC Protein, CF |
Description | Purity >97%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (theoretical): 7.8 kDa. The Recombinant Human CCL18/PARC Protein from R&D Systems is derived from E. coli. The Recombinant Human CCL18/PARC Protein has been validated for the following applications: Bioactivity. |
Size | 50 ug |
Concentration | n/a |
Applications | Bioactivity |
Other Names | Alternative macrophage activation-associated CC chemokine 1, AMAC-1, AMAC1CC chemokine ligand 18, AMAC-1Small-inducible cytokine A18, chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated), CKb7, DC-CK1, DC-CK1CC chemokine PARC, DCCK1Macrophage inflammatory protein 4, Dendritic cell chemokine 1, MIP4, MIP-4, MIP-4C-C motif chemokine 18, PARC, PARCPulmonary and activation-regulated chemokine, SCYA18chemokine (C-C), dendritic, small inducible cytokine A18, small inducible cytokine subfamily A (Cys-Cys), member 18, pulmonary andactivation-regulated |
Gene, Accession, CAS # | CCL18, Gene ID: 6362, Accession: P55774.1 |
Catalog # | 394-PA-050/CF |
Price | |
Order / More Info | Recombinant Human CCL18/PARC Protein, CF from R&D SYSTEMS, INC. |
Product Specific References | PubMed: 12450563, 15661937, 16603217, 20002784, 21075651, 21200186, 22763448, 28533380 |
产品资料 |
|
|